AmBisome News
Most Popular AmBisome Story
Gilead SEC filing anticipates FDA warning letter
HIV treatment maker Gilead Sciences says it soon may be the recipient of an FDA warning letter. During a routine inspection of its San Dimas, CA, facility at the beginning of the year, the regulator Read more...
Latest Headlines
- August 9, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
